Plain-English translation of NCT07507370 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Major Depressive Disorder research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The CARED trial is testing a new one-day treatment approach for depression that doesn't respond to typical antidepressant medications. This treatment combines talk therapy with two types of non-invasive brain stimulation: one called iTBS and another called tACS. Researchers want to see if doing all three treatments together in a single session can safely reduce depression symptoms and improve how people feel.
Many people with depression don't get better even after trying multiple antidepressant medications, and they need faster, more effective options. This trial is exploring whether combining psychotherapy with targeted brain stimulation might offer relief for people stuck in that situation.
You likely qualify if…
You likely don't qualify if…
You would come for one full day of treatment during which you'll receive talk therapy, followed by two types of brain stimulation delivered through electrodes on your scalp—none of it is invasive or painful. You'll then return for check-in visits 2 weeks and 3 months later to complete questionnaires and assessments measuring how you're feeling. The entire study takes place over 3 months, with most of the active treatment happening in that single session.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States